Oscar Health (OSCR) Common Equity (2020 - 2026)

Oscar Health's Common Equity history runs 7 years deep, the most recent figure standing at $1.7 billion for Q1 2026.

• Quarterly Common Equity rose 24.77% year-over-year to $1.7 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.7 billion (up 24.77% YoY) and the FY2025 annual result came in at $977.6 million, up 48882300.0% from the prior year.
• Common Equity was $1.7 billion for Q1 2026 at Oscar Health, up from $977.6 million in the prior quarter.
• Across five years, Common Equity topped out at $1.7 billion in Q1 2026 and bottomed at -$6.9 million in Q2 2023.
• A 5-year average of $832.5 million and a median of $977.6 million in 2025 frame the typical range for Common Equity.
• Annual changes were most pronounced in 2023 — Common Equity slumped 100.55% — and 2025, when it surged 48882300.0%.
• Oscar Health's Common Equity stood at $1.1 billion in 2022, then slipped by 25.67% to $806.1 million in 2023, then sank by 100.0% to $2000.0 in 2024, then jumped by 48882300.0% to $977.6 million in 2025, then jumped by 70.52% to $1.7 billion in 2026.
• Business Quant data shows OSCR's Common Equity at $1.7 billion in Q1 2026, $977.6 million in Q4 2025, and $1.0 billion in Q3 2025.